BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Vitamin E
,
rs7903146
,
BRAF
,
calcium channel activity
,
Allergy to pollen
,
Stem cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Brg1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Natural killer cell of peripheral blood
Fetal brain
Nipple cross-section
Testes
Oral mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Intestinal infectious disease
Injury of eye region
Irritable bowel syndrome
Multiple organ failure
Muscle cachexia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
naphthalene
Carteolol
naphthalan
Desoxycorticosterone
Chloroprene
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
hsa-miR-365a-3p
PDSS2
RCHY1
SMARCA4
PLPP1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Knockdown of Brg1 reduced mucus secretion in HDM stimulated airway inflammation.
Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway.
Defining the first bona fide cell model for SMARCA4-deficient, undifferentiated tumor.
Brahma-related gene 1 acts as a profibrotic mediator and targeting it by micheliolide ameliorates pe…
Brg1 is required to maintain colorectal cancer stem cells.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
A Study of LY3405105 in Participants With Advanced Cancer
Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
FHD-286 in Subjects With Metastatic Uveal Melanoma
FHD-286 in Subjects With Advanced Hematologic Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ